Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead.
Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. · Investor's Business Daily

In This Article:

Arcellx stock reversed lower Monday on positive results for its rival to Legend Biotech's multiple myeloma treatment, Carvykti.